ConductScience.org, home

Paper2245178

Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours.

Desoize B and 2 others. Br J Cancer, 1990. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours. Papers, record 2245178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2245178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours.
PubMed
Journal
Br J Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.4
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Desoize BB
2Marechal FF
3Cattan AA

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EtoposideMajor topic
NeoplasmsMajor topic
Humans
Infusions, Parenteral
Time Factors

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17459811Reporting results of cancer treatment.Cancer1981https://conductscience.org/library/papers/7459811PubMed
23888428Anticancer drug pharmacodynamics.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3888428PubMed
33697995Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function.Cancer Res1986https://conductscience.org/library/papers/3697995PubMed
43018396Etoposide: a pharmacokinetic profile including an assessment of bioavailability.Med Oncol Tumor Pharmacother1986https://conductscience.org/library/papers/3018396PubMed
52747579Superiority of perfusion over bolus administration in cancer chemotherapy: proposition of a compartmental model.Med Hypotheses1989https://conductscience.org/library/papers/2747579PubMed
63598607Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial.J Clin Oncol1987https://conductscience.org/library/papers/3598607PubMed
72920497Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability.Clin Pharmacol Ther1989https://conductscience.org/library/papers/2920497PubMed
82926468A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.J Clin Oncol1989https://conductscience.org/library/papers/2926468PubMed
93297462The clinical pharmacology of etoposide and teniposide.Clin Pharmacokinet1987https://conductscience.org/library/papers/3297462PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
16353925Population pharmacokinetic studies in pediatrics: issues in design and analysis.AAPS J2005https://conductscience.org/library/papers/16353925PubMed
12361242Limited and optimal sampling strategies for etoposide and etoposide catechol in children with leukemia.J Pharmacokinet Pharmacodyn2002https://conductscience.org/library/papers/12361242PubMed
11108434Pharmacokinetically guided administration of chemotherapeutic agents.Clin Pharmacokinet2000https://conductscience.org/library/papers/11108434PubMed
10803455Adaptive control methods for the dose individualisation of anticancer agents.Clin Pharmacokinet2000https://conductscience.org/library/papers/10803455PubMed
9878990Practical treatment guide for dose individualisation in cancer chemotherapy.Drugs1998https://conductscience.org/library/papers/9878990PubMed
9761935Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy.Pathol Oncol Res1998https://conductscience.org/library/papers/9761935PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2245178

GET https://conductscience.org/api/papers/v1/2245178/authors